Injection of seasonal flu vaccine into tumors converts immunologically cold tumors to hot, generates systemic responses and serves as an immunotherapy for cancer, reports new study in mice. Repurposing the “flu shot”, based on its current FDA approval, may be quickly translated for clinical care.

Injection of seasonal flu vaccine into tumors converts immunologically cold tumors to hot, generates systemic responses and serves as an immunotherapy for cancer, reports new study in mice. Repurposing the “flu shot”, based on its current FDA approval, may be quickly translated for clinical care.

December 30, 2019

Injection of seasonal flu vaccine into tumors converts immunologically cold tumors to hot, generates systemic responses and serves as an immunotherapy for cancer, reports new study in mice. Repurposing the “flu shot”, based on its current FDA approval, may be quickly translated for clinical care.

submitted by /u/mvea
[link] [comments]

Comments